Literature DB >> 28103752

MynxGrip for Closure of Antegrade Puncture After Peripheral Interventions With Same-Day Discharge.

Maciej J Pruski1, Aleksandra M Blachut1, Magda Konkolewska1, Adam Janas1, Eugeniusz Hrycek1, Piotr P Buszman1, Radoslaw S Kiesz2.   

Abstract

BACKGROUND: This was the first prospective study to assess the safety and efficiency of MynxGrip vascular closure device (VCD) in peripheral interventions with antegrade access. METHODS AND
RESULTS: We enrolled 66 consecutive patients from 1 center. All patients were discharged home on the day of procedure and were observed for adverse events at 1 and 30 days of follow-up. No major complications were observed. The rate of minor complications (conversion to manual or mechanical compression) was 7.6%. Postdischarge, 3% of patients experienced minor complications-small abscess, ipsilateral deep vein thrombosis. In 1 patient, a second VCD was deployed after device failure. The derived device failure rate was 5.9%. No patients required hospitalization. No late bleeding and no hematomas >6 cm were noted. The mean time to discharge was 4 hours and 5 minutes.
CONCLUSION: The MynxGrip was safe and effective in sealing access sites after antegrade femoral artery puncture with same-day discharge.

Entities:  

Keywords:  endovascular procedures; peripheral arterial disease; vascular closure devices

Mesh:

Year:  2017        PMID: 28103752     DOI: 10.1177/1538574416689424

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Antegrade common femoral artery closure device use is associated with decreased complications.

Authors:  Joel L Ramirez; Devin S Zarkowsky; Thomas A Sorrentino; Caitlin W Hicks; Shant M Vartanian; Warren J Gasper; Michael S Conte; James C Iannuzzi
Journal:  J Vasc Surg       Date:  2020-03-09       Impact factor: 4.268

2.  Comparison of MynxGrip vascular closure device and manual compression for closure after femoral access angiography: a randomized controlled trial: the closure devices used in every day practice study, CLOSE-UP III trial.

Authors:  Lars Jakobsen; Niels R Holm; Michael Maeng; Troels Thim; Steen D Kristensen; Lone H Mogensen; Evald H Christiansen
Journal:  BMC Cardiovasc Disord       Date:  2022-02-23       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.